ICICI Securities research report on IndusInd Bank
As opposed to the three-year term requested by IndusInd Bank’s (IIB) board for its incumbent MD & CEO, Mr Sumant Kathpalia, RBI has approved a term renewal for only one year. This is the second consecutive instance, when Mr Kathpalia has been denied full term by RBI. We believe this may lead to deliberation on how the regulator could be construing individual capability/suitability or governance of the institution, or both. We believe the board could begin considering an MD & CEO succession plan, which may include external candidates as well. We see heightened uncertainty in the near term on possible kitchen sinking, and probable names of MD&CEO candidate.
Outlook
We downgrade IIB to REDUCE (from Buy) with a revised TP of INR 850 (INR 1,350), valuing the stock at ~0.9x FY26E ABV. Risks: Better-than-expected growth; and seamless management transition.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
